Related Experiment Video
Updated: May 8, 2025
04:36
Author Spotlight: Understanding Retinal Vessel Resilience and Disease Progression
Published on: January 12, 2024
983
[Diabetic retinopathy and pregnancy].
N V Pomytkina1,2, E L Sorokin1,2
1Khabarovsk branch of S.N. Fedorov National Medical Research Center "MNTK "Eye Microsurgery", Khabarovsk, Russia.
Vestnik Oftalmologii
|December 28, 2024
Summary
Diabetic retinopathy (DR) is a serious concern for pregnant women with diabetes mellitus (DM). This review covers DR progression, causes, risks, and prevention during pregnancy.
Area of Science:
- Ophthalmology
- Endocrinology
- Maternal-Fetal Medicine
Background:
- Diabetic retinopathy (DR) is a leading cause of vision loss.
- Pregnancy in women with diabetes mellitus (DM) can accelerate DR progression.
- Understanding these changes is crucial for maternal and fetal health.
Purpose of the Study:
- To review the critical issue of diabetic retinopathy (DR) in pregnant women with diabetes mellitus (DM).
- To describe the current understanding of DM progression during pregnancy.
- To outline pathogenic mechanisms, risk factors, and preventive measures for DR during gestation.
Main Methods:
- Literature review of existing studies on diabetic retinopathy in pregnant diabetic patients.
- Synthesis of information on disease progression, pathogenesis, and risk factors.
- Analysis of current preventive strategies.
Main Results:
- Pregnancy can significantly impact the progression of diabetic retinopathy.
- Specific pathogenic mechanisms and risk factors contribute to DR manifestation and worsening during gestation.
- Evidence-based preventive measures are essential for managing DR in this population.
Conclusions:
- Pregnant women with DM require careful monitoring for diabetic retinopathy.
- Early detection and intervention are key to preventing vision loss.
- Multidisciplinary management is recommended for optimal outcomes.
Related Concept Videos
01:22Diabetes Mellitus: Type 2 and Gestational
2.1K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.1K
01:20Pathophysiology of Diabetes
780
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
780
01:15Diabetes: Symptoms, Diagnosis, and Complications
466
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
466
01:22Diabetes Mellitus: Overview and Type I Subtype
2.3K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.3K
01:15Diabetes: Management and Pharmacotherapy
203
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
203
01:22Photoreceptors and Visual Pathways
5.4K
At the molecular level, visual signals trigger transformations in photopigment molecules, resulting in changes in the photoreceptor cell's membrane potential. The photon's energy level is denoted by its wavelength, with each specific wavelength of visible light associated with a distinct color. The spectral range of visible light, classified as electromagnetic radiation, spans from 380 to 720 nm. Electromagnetic radiation wavelengths exceeding 720 nm fall under the infrared category,...
5.4K